Lakeshore Acquisition III Corp. (LCCCR)

Lakeshore Acquisition III Corp. (LCCCR) is the ticker for the rights component of Lakeshore Acquisition III. When the company’s units separated in June 2025, the rights began trading independently on the Nasdaq Global Market. Unlike warrants, which are traded standardly across SPACs, rights are less common and their terms vary company by company. A right entitles the holder to buy additional shares when the SPAC closes its business combination, usually at a specified price per share set at the time of the IPO.

How rights work in a SPAC structure

The mechanics are straightforward in principle. A holder of Lakeshore rights receives the contractual ability to purchase a fixed number of additional shares of Lakeshore at a set price — typically between 10 and 11.50 dollars per share, depending on how the rights were structured in the IPO prospectus — at or shortly after the business combination closes. That fixed price is the exercise price or strike price.

If the combined company’s stock trades at $15 per share after the deal closes, a right to buy one share at $11 is worth approximately $4. If the stock trades at $8, the right is worthless; the holder will not exercise it. This is pure leverage: a right holder who buys the right for, say, $1 can potentially make a large return if the deal succeeds and the stock soars, or lose the entire $1 if the deal fails or the stock flatlines.

Rights are less visible than warrants in SPAC documents and marketing, but they serve the same purpose from a sponsor’s perspective: they are a way to align investor interests with deal success. Investors who buy rights are making a binary bet: the SPAC must close a deal that results in a stock price high enough to make the exercise profitable.

The cyclicality bet embedded in rights

The value of rights is entirely dependent on three things: whether the deal closes, what price the combined company trades at post-close, and how long the rights remain exercisable. In a boom market, when SPAC deals are finishing regularly and emerging companies are valued richly, rights are valuable and actively traded. In a tight market, when redemption rates are high and post-deal stocks struggle to gain traction, rights are nearly worthless.

Lakeshore III’s rights were created and began trading in mid-2025, a period when the SPAC market had cooled considerably from its 2020–2021 frenzy. That context matters: the investor who buys LCCCR is betting not only that Lakeshore will find and close an acquisition, but that public shareholders will stick with the deal and not redeem in such large numbers that the combined company emerges undercapitalized, and that the resulting company will be valued favorably when trading begins. Each of those bets is tougher in a downturn than in a boom.

Practical considerations for research

The relevant documents are the IPO prospectus for Lakeshore Acquisition III, which details the exact terms of the rights — how many shares each right entitles the holder to buy, the exercise price, the exercise period, and any anti-dilution adjustments. The prospectus also contains the sponsor’s stated acquisition criteria and track record, clues about what kind of company they might pursue and whether past acquisitions performed well.

Once Lakeshore announces a business combination, the proxy statement filed with the SEC will reveal the deal’s valuation and structure. At that moment, rights holders can attempt to estimate whether the combined company’s stock is likely to trade high enough to make the rights in-the-money. Watch the redemption rate: if more than 50 percent of public shares redeem, the combined company will have less capital than the original SPAC raised, a structural weakness that often depresses stock performance and makes rights worthless.

Finally, note that rights have an expiration date. Unlike a stock, which can be held indefinitely, a right to purchase shares expires on a specified date. After that date, the right has no value. This time limit creates urgency: rights holders must monitor the combined company’s stock price and exercise or sell before expiration, adding complexity and trading risk compared to holding ordinary shares.